Phase I study of tirabrutinib (ONO-4059/GS-4059) in patients with relapsed or refractory B-cell malignancies in Japan.
Cancer Sci
; 110(5): 1686-1694, 2019 May.
Article
in En
| MEDLINE
| ID: mdl-30815927
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Pyrimidines
/
Leukemia, Lymphocytic, Chronic, B-Cell
/
Protein Kinase Inhibitors
/
Imidazoles
/
Neoplasm Recurrence, Local
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Cancer Sci
Year:
2019
Type:
Article
Affiliation country:
Japan